Evofem financials
WebMar 10, 2024 · SAN DIEGO, March 3, 2024 - Evofem Biosciences, Inc. (Nasdaq: EVFM), a commercial stage biopharmaceutical company, today reported financial results for the … WebApr 10, 2024 · Evofem’s latest round of blood-letting will cut about $4.3 million in expenses, buying her company another few months of operating budget, while she keeps searching for a buyer or investor or ...
Evofem financials
Did you know?
WebFinancials. Annual Quarterly ... Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. It is engaged in developing and commercializing products to address unmet needs in women ... WebApr 14, 2024 · Evofem Biosciences, Inc., (OTCQB: EVFM), the maker of Phexxi® (lactic acid, citric acid and potassium bitartrate), today announced the appointment of Ivy Zhang as Chief Financial Officer (CFO ...
WebAug 4, 2024 · Evofem continues to expect net product sales in the range of $30 to $35 million for its 2024 fiscal year, representing 264% to 325% growth year-over-year. Gross-to-net is expected to be 40% or ... WebEvofem Biosciences Inc. SEC filings breakout by MarketWatch. View the EVFM U.S. Securities and Exchange Commission reporting information.
WebGet the detailed quarterly/annual income statement for Evofem Biosciences, Inc. (EVFM). Find out the revenue, expenses and profit or loss over the last fiscal year. Find the latest Evofem Biosciences, Inc. (EVFM) stock discussion in Yahoo … Find out the direct holders, institutional holders and mutual fund holders for … Interactive Chart for Evofem Biosciences, Inc. (EVFM), analyze all the data with a … View the basic EVFM option chain and compare options of Evofem … Find out all the key statistics for Evofem Biosciences, Inc. (EVFM), including … See Evofem Biosciences, Inc. (EVFM) stock analyst estimates, including earnings … Evofem Biosciences, Inc. 12400 High Bluff Drive Suite 600 San Diego, CA 92130 … WebMar 6, 2024 · Item 1.01 Entry into a Material Definitive Agreement. Securities Purchase Agreement. On March 13, 2024, Evofem Biosciences, Inc., a Delaware corporation (the "Company"), entered into a securities purchase agreement ("SPA"), effective March 6, 2024, with certain investors (the "Investors") providing for the sale and issuance of senior …
WebApr 6, 2024 · 62,6%. More Financials. Company. Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. It is engaged in developing and commercializing products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from …
WebJan 17, 2024 · Evofem Biosciences has raised a total of $470.8M in funding over 16 rounds. Their latest funding was raised on May 20, 2024 from a Post-IPO Equity round. Evofem … myhealth mckinleyWeb2 days ago · In the first quarter of 2024, Evofem gained Phexxi coverage for 16.3 million new lives from payers including Mississippi Medicaid, Indiana State Medicaid, multiple Blue Cross Blue Shield plans ... ohio buckeyes team colorsWebGet the latest Evofem Biosciences Inc (EVFM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … my health m cityWebLegal Name Evofem Biosciences, Inc. Stock Symbol NASDAQ:EVFM. Company Type For Profit. Contact Email [email protected]. Phone Number +858.550.1900. Evofem is a biopharmaceutical company that offers women's reproductive and contraceptive care products. The company's first commercial product, Phexxi, is the first and only hormone … myhealth mcity claytonWebEvofem Biosciences Inc's (NASDAQ: EVFM) Q2 Phexxi sales increased 42% Y/Y to $6.0 million, reflecting higher ex-factory sales and lower gross-to-net adjustments of 40%. my health mcity claytonWebApr 14, 2024 · SAN DIEGO, April 14, 2024--Evofem Biosciences, Inc., (OTCQB: EVFM), the maker of Phexxi® (lactic acid, citric acid and potassium bitartrate), today announced … ohio buckeye shrubWebEvofem Biosciences Inc. Annual stock financials by MarketWatch. View the latest EVFM financial statements, income statements and financial ratios. ohio buckeye soccer league